Table 3.
Variables Associated with Incident OUDs
| Variables# | UNADJUSTED OR (95% CI) | ADJUSTED OR (95% CI) |
|---|---|---|
| Opioid Dose and Days | ||
| No opioid use (Reference) | 1.00 (--) | 1.00 (--) |
| Low dose, acute | 3.31 (2.54 – 4.31)*** | 3.03 (2.32 – 3.95)*** |
| Low dose, chronic | 17.63 (12.33 – 25.20)*** | 14.92 (10.38 – 21.46)*** |
| Med dose, acute | 3.04 (2.30 – 4.01)*** | 2.80 (2.12 – 3.71)*** |
| Med dose, chronic | 35.19 (24.75 – 50.02)*** | 28.69 (20.02 – 41.13)*** |
| High dose, acute | 2.68 (1.45 –4.98)** | 3.10 (1.67 – 5.77)*** |
| High dose, chronic | 171.95 (105.97 – 279.00)*** | 122.45 (72.79 – 205.99)*** |
| Age in Years – N (%) | ||
| 18–30 | 14.12 (7.43 – 26.86)*** | 10.51 (5.47 – 20.20)*** |
| 31–40 | 6.45 (3.37 – 12.33)*** | 4.62 (2.39 – 8.91)*** |
| 41–50 | 4.60 (2.40 – 8.80)*** | 3.27 (1.70 – 6.30)*** |
| 51–64 | 2.08 (1.44 – 5.44)** | 2.18 (1.12 – 4.26)* |
| >=65 - Reference Group | 1.00 (--) | 1.00 (--) |
| Sex | ||
| Female - Reference Group | 1.00 (--) | 1.00 (--) |
| Male | 2.38 (1.96 – 2.91)*** | 2.27 (1.85 – 2.78)*** |
| Charlson score (Pre) | 1.01 (0.83 – 1.22) | 1.11 (0.93 – 1.34) |
| # of types of tracer pains (of 5) in the PRE Index period | ||
| None – Reference Group | 1.00 (--) | 1.00 (--) |
| One | 0.73 (0.51 –1.04) | 0.76 (0.52 – 1.10) |
| Two or more | 1.53 (0.72 – 3.23) | 1.37 (0.63 – 3.01) |
| Number of Non-Tracer Pain Categories | ||
| 0 – Reference Group | 1.00 (--) | 1.00 (--) |
| 1 | 0.68 (0.53 – 0.87)** | 0.72 (0.56 – 0.93)** |
| 2–3 | 0.88 (0.63 – 1.22) | 0.95 (0.67 – 1.35) |
| 4+ | 2.37 (0.98 – 5.74) | 2.62 (1.05 – 6.55)* |
| Number of Non-Substance Mental Health Disorder Types | ||
| 0 – Reference Group | ||
| 1 | 3.85 (3.02 – 4.92)*** | 3.12 (2.41 – 4.04)*** |
| 2+ | 8.37 (5.78–12.12)*** | 5.71 (3.83 – 8.52)*** |
| Pre-index Substance Abuse/Dependence Diagnoses | ||
| Non-Opioid | 60.95 (39.34 – 94.44)*** | 8.26 (4.74 – 14.39)*** |
| Alcohol | 23.35 (14.51 – 37.58)*** | 3.22 (1.79 – 5.80)*** |
All independent variables, except the opioid variables (days supply, dose, category type) were measured in the 12 months prior to the index date. Opioid variables were measured in the 12-month period after the index date.
p<0.05
p<0.01
p<0.001